IPO Listed
Alamar Biosciences IPO
US$191m raised
Lodged 16 Apr 2026 · NASDAQ: ALMR · US$17.00 cash per share
Advisers
Lead managers
- Legal adviser
- Issuer
- Alamar Biosciences
- Issuer based in
- United States
- Listed
- 20 Apr 2026
- Sector
- Life Sciences
- Tags
- Life Sciences, Diagnostics
In the league tables
Similar deals
- Freenome placement Dec 2025 · US$240m · Diagnostics
- Clarity Pharmaceuticals placement Jul 2025 · US$133m · Healthcare
- PYC Therapeutics entitlement offer Feb 2025 · US$90.8m · Healthcare
- PYC Therapeutics entitlement offer Feb 2026 · US$464m · Healthcare
- Botanix Pharmaceuticals placement Feb 2026 · US$28.4m · Healthcare
Sources
- 17 Apr 2026 Final IPO prospectus (424B4), Alamar Biosciences, Inc. sec.gov
- 17 Apr 2026 Latham Watkins Advises on Alamar Biosciences Upsized Initial Public Offering lw.com
- 20 Apr 2026 Alamar Biosciences Announces Upsized $219.9 Million IPO cooley.com



